Treatment-Naive B Cell Malignancies
1 clinical trials · Condition
◉ Watch Treatment-Naive B Cell Malignancies
| Record | Firm | Date |
|---|---|---|
| Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL Subjects (NCT02825836) | Telios Pharma, Inc. | 2016-08-26 |
Track Treatment-Naive B Cell Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.